Semnur Pharmaceuticals, Inc. (SMNR) IPO - S-1 Filing, Stock & Insider Activity
Semnur Pharmaceuticals, Inc. IPO - Status & S-1 Filing
- Ticker: SMNR
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2025-12-19
- Exchange: NASDAQ
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- Shares offered: 203,737,349
- SEC CIK: 0001913577 · View the S-1 on SEC EDGAR →
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
Semnur Pharmaceuticals, Inc. (SMNR) has filed 1 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-26. 2 Form 8-K material event filings were reported by SMNR in the last 90 days. InsiderAlpha tracks every SMNR SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Semnur Pharmaceuticals, Inc. (SMNR)
Semnur Pharmaceuticals, Inc. trades under the ticker SMNR. InsiderAlpha tracks 2 primary SEC Form 4 filings from 1 reporting insider for SMNR since 2025, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001913577 |
90-Day SEC Filing Activity
| Form 4 filings (90d) | 1 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Latest Form 4 filing | 2026-06-26 |
Recent SMNR Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Scilex Holding Co | Insider | J - Other acquisition / disposition | 7.03M | $0.00 | - | SEC | |
| Scilex Holding Co | Insider | S - Open-market sale | 11.95M | $16.00 | $191.12M | SEC | |
| Scilex Holding Co | Insider | S - Open-market sale | 554.8K | $16.00 | $8.88M | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Semnur Pharmaceuticals, Inc. (SMNR). Updated in real time as new filings are submitted to the SEC.
Most-Active SMNR Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Scilex Holding Co | 1 | - |
Recent SMNR Form 8-K Material Events
- - Item 1.01, 3.02, 7.01, 9.01 [SEC]
- - Item 5.07, 9.01 [SEC]
- - Item 1.02 · Financing · negative [SEC]
Semnur Pharmaceuticals terminated a PIPE (Private Investment in Public Equity) agreement with JW Capital Securities Limited that was supposed to bring in $20 million (1.25M shares at $16/share) following the company's September 2025 business combination. The termination indicates - - Item 5.02, 9.01 · Leadership · negative [SEC]
Jaisim Shah, CEO and President of Semnur Pharmaceuticals, retired and resigned effective March 13, 2026. The departure was not due to disagreement and Shah will receive six months of continued base salary ($625,000) and a 90-day extension to exercise vested stock options under a
Recent Insider Filings
- - Scilex Holding Co (Insider)
- - Scilex Holding Co (Insider)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in SMNR insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
SMNR Insider Trading - FAQ
- What is the latest insider trade for SMNR?
- Semnur Pharmaceuticals, Inc. (SMNR) had 1 insider filings in the last 90 days, with the most recent on 2026-06-26. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying SMNR stock?
- 0 insider purchases of SMNR were filed in the last 90 days.
- How many insiders are selling SMNR stock?
- 0 insider sales of SMNR were filed in the last 90 days.
- Where can I see SMNR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks SMNR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $SNDA SONIDA SENIOR LIVING, INC.
- $SNYR Synergy CHC Corp.
- $SRRK Scholar Rock Holding Corp
- $SSII SS Innovations International, Inc.
- $STAA STAAR SURGICAL CO
- $STTK Shattuck Labs, Inc.
- $TCRX TScan Therapeutics, Inc.
- $TECX Tectonic Therapeutic, Inc.
- $TNON Tenon Medical, Inc.
- $TYRA Tyra Biosciences, Inc.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live SMNR dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.